• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 7, Issue 10
  3. Author

Online ISSN: 2515-8260

Volume7, Issue10

A prospective, comparative study of N-acetyl cysteine with metformin on clinical profile in an ovulatory infertile woman with PCOS

    Dr. Anupam Kumari, Dr. Jayanti Sinha, Dr. Sweety Sinha

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 10, Pages 4003-4008

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Aim: To compared the efficacy of Metformin and NAC on clinical, metabolic, hormonal, sonographic and fertility aspects among PCOS patients.
Material and methods: A prospective, comparative study was conducted in the Department of Obstetrics & Gynaecology, NSMCH, Bihta, Patna, Bihar, India, for 1 year. 120 women with PCOS (diagnosed by Rotterdam criteria) of age group 18–37 year were included in this study. Serum TSH, serum prolactin, serum follicle-stimulating hormone, luteinizing hormone (mIU/L), LH/FSH ratio, serum fasting insulin, serum fasting glucose level, serum fasting glucose/insulin ratio and serum total testosterone were measured by enzyme immune assay(EIA). Ultrasonography examination (TAS and TVS) was done preferably on day 2 or 3 of menstruation. Subjects were randomly assigned into two treatment groups. Group M received metformin 500 mg three times a day. Group N received N acetyl cysteine, 600 mg three times a day.
Results: Out of 120 cases, 20 were lost to follow-up. In remaining 100 cases, 50 were in Group M, 50 were in Group N. The cases in Group M received tab metformin 500 mg three times a day, and Group N received tab N acetyl cysteine 600 mg three times a day. After 24 weeks of treatment with either metformin or NAC clinical characteristic, metabolic parameter and hormonal profile were re-evaluated. There was no significant reduction of weight in both the group after treatment, while a significant reduction of BMI, WC and WHR was found in Group N receiving NAC. Fasting glucose and fasting insulin were reduced in both groups significantly. There was a significant improvement of fasting glucose/insulin ratio in both groups. Total testosterone was significantly reduced in Group N.
Conclusion: we concluded that the better improvement of metabolic and hormonal profile was observed in N acetyl cysteine group. Because of its less side effect comparing to metformin, NAC can be used as a substitute for insulin-sensitizing agent in treatment of PCOS.
Keywords:
  • PDF (259 K)
  • XML
(2021). A prospective, comparative study of N-acetyl cysteine with metformin on clinical profile in an ovulatory infertile woman with PCOS. European Journal of Molecular & Clinical Medicine, 7(10), 4003-4008.
Dr. Anupam Kumari, Dr. Jayanti Sinha, Dr. Sweety Sinha. "A prospective, comparative study of N-acetyl cysteine with metformin on clinical profile in an ovulatory infertile woman with PCOS". European Journal of Molecular & Clinical Medicine, 7, 10, 2021, 4003-4008.
(2021). 'A prospective, comparative study of N-acetyl cysteine with metformin on clinical profile in an ovulatory infertile woman with PCOS', European Journal of Molecular & Clinical Medicine, 7(10), pp. 4003-4008.
A prospective, comparative study of N-acetyl cysteine with metformin on clinical profile in an ovulatory infertile woman with PCOS. European Journal of Molecular & Clinical Medicine, 2021; 7(10): 4003-4008.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 59
  • PDF Download: 120
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus